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Abstract
Background The aim of this study is to investigate how
the Charlson Comorbidity Index (CCI) scores contribute to
increased length of stay (LOS) and healthcare costs in hip
fracture patients.
Materials and methods Through retrospective analysis at
an Urban level I trauma center, charts for all patients over
the age of 60 years who presented with low-energy hip
fracture were evaluated. 615 patients who underwent op-
erative fixation of hip fracture or hemiarthroplasty sec-
ondary to hip fracture were identified using Current
Procedural Terminology (CPT) codes search and included
in the study. Data was collected on patient demographics,
medical comorbidities, and hospitalization length; from
this, the CCI score and the cost to the institution (with
an average cost/day of inpatient stay of $4,530) were
calculated.
Results Multivariate linear regression analysis modeled
the length of stay as a function of CCI score. Each unit
increase in the CCI score corresponded to an increase in
length of hospital stay and hospital costs incurred [effect
size = 0.21; (0.0434–0.381); p = 0.014]. Patients with a
CCI score of 2 (compared to a baseline CCI score of 0), on
average, stayed 1.92 extra days in the hospital, and in-
curred $8,697.60 extra costs.
Conclusions The CCI score is associated with length of
stay and hospital costs incurred following treatment for hip
fracture. The CCI score may be a useful tool for risk
assessment in bundled payment plans.
Level of evidence Level III.
Keywords Charlson Comorbidity Index  Costs  Length
of stay (LOS)
Introduction
Hip fracture procedure volumes have risen in recent years,
largely due to an aging population, and this trend is ex-
pected to increase dramatically in the coming decades,
from 250,000 procedures annually to 500,000 by 2040 [1].
With current estimates of treating a hip fracture averaging
$11,844–13,805, bundled payments have been proposed to
contain costs without sacrificing quality in hip fracture
treatment [2–4]. Bundled payments, otherwise known as
episode-of-care payments, set a fixed reimbursement
amount that collectively holds all providers responsible for
patient outcomes. A key component of episode-based
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payment is that it attributes an episode of care as the length
of time that an ‘‘average’’ patient would need for a certain
intervention, and any increase in cost due to an unplanned
prolonged length of stay (LOS) may have a significant
negative financial impact on any institution caring for a hip
fracture patient [5]. To protect the institution from incur-
ring such costs, it is imperative to identify the patient
factors that are associated with increased costs, and to
develop methods to standardize their weighting and quan-
tify their economic impact.
A number of scoring systems which summarize the pa-
tient’s overall health status have been developed, including
the American Society of Anesthesiologist’s score (the ASA
score), the Elixhauser score, and the Charlson Comorbidity
Index (CCI). Higher ASA scores have been shown to be
associated with increased hospital costs secondary to in-
creased LOS in hip fracture patients [6]. Similarly, work by
Nikkel et al. [2] demonstrated that higher Elixhauser scores
are correlated with increased length of hospitalization and
hospital costs incurred in hip fracture patients. Higher
Charlson Comorbidity Index scores have been shown to
correlate with increased 30-day mortality after hip fractures
[7], increased 90-day mortality after hip fractures [8], in-
creased in-hospital mortality in patients with hip fractures
[9], and readmission rates after orthopedic procedures, in-
cluding treatment of hip fractures [10]. Data about the re-
lationship between CCI and LOS following hip fracture is
limited, and at the present time, there are no studies to our
knowledge, looking at the relationship between CCI scores
and length of hospitalization in the United States; therefore,
this study assesses the relationship between CCI, as a useful
indicator of patient health and LOS following hip fracture,
and estimates additional hospital costs that may be used to
weight bundled payments.
Materials and methods
Institutional review board approval was obtained for this
study. This was a retrospective cohort study that included
all patients who underwent operative fixation of hip frac-
ture or hemiarthroplasty secondary to hip fracture, in-
cluding both femoral neck fractures and intertrochanteric
fractures, at Vanderbilt University Medical Center, a level
one trauma center, from January 2000 to December 2009.
Current Procedural Terminology (CPT) codes were used to
find patients who had experienced a hip fracture from
a low-energy fall and received an intervention of
cephalomeduallary nailing (CMN), closed reduction and
percutaneous pinning (CRPP), total hip arthroplasty
(THR), hemiarthroplasty (hemi), or open reduction internal
fixation (ORIF). All patients over the age of 60 years
with acetabular, proximal femoral, femoral neck, and
trochanteric fractures were selected. Patients with incom-
plete medical records were excluded. Additional demo-
graphic and clinical covariates were collected from our
institution’s electronic medical records database. Medical
comorbidities were documented preoperatively by routine
preoperative assessment, and, from this data, the Charlson
Comorbidity Index was calculated according to Deyo’s
description [11].
The average total cost to the hospital of an inpatient day
($4,530 per day) was obtained from the institution’s fi-
nancial services and the average cost was treated as a unit
cost per inpatient day. All fractional LOS values were
rounded to the nearest whole number and multiplied by the
per day cost.
The primary outcome of interest was the relationship
between the CCI and the length of hospitalization. Risk of
the occurrence of the outcome of interest (i.e. LOS) was
modeled as a function of the preoperative CCI using
multivariable linear regression. The multivariate linear re-
gression model controlled for confounders (gender, ASA,
body mass index, race, smoking status, anesthesia type and
comorbidities) previously found to be associated with the
outcome (i.e. prolonged LOS). Statistical significance was
set at p = 0.05.
Results
Six hundred and fifteen complete records were obtained for
isolated low-energy hip fractures in patients 60 years or
older who were treated at our Level 1 trauma center. The
average age of the hip fracture patient was 78.4 years and
51.7 % of our patients were aged 75–89 years. Caucasians
comprised the majority of our patient cohort (84.7 %),
followed by African-Americans (7.3 %). Nearly three-
quarters of our patient cohort had a CCI score less than 3,
and more than half of the cohort had a CCI score of either 0
or 1. Patient characteristics and demographic data are
summarized in Table 1.
The different surgical procedures performed, classified
by CPT codes, and the average LOS and hospital costs
incurred for the inpatient stay are summarized in Table 2.
The three most common procedures, representing 52.7 %
of the procedures performed, were partial hip hemiarthro-
plasty (CPT code 7125; 19.7 %), open reduction and in-
ternal fixation of inter/per/subtrochanteric fracture with
plate or screw, with/without cerclage (CPT 27244;
19.0 %), and open reduction and internal fixation of
femoral neck fracture (CPT 27236; 14.0 %). These three
procedures had an average LOS of 7.37 days with an av-
erage cost of $33,401. Overall, for all the procedures, the
average LOS was 5.84 days and the average cost was
$26,470 with a median of $27,180.
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Male gender (which represented 33 % of our cohort)
was also significantly associated with an additional 1.12
(95 % CI 0.375–1.865) days in hospital (p = 0.003); the
financial implication of this finding is that each male pa-
tient costs the hospital an additional $5,073.60 as compared
to a female patient (see Table 1). There was also an as-
sociation between smoking status and hip fractures, but this
did not reach statistical significance, probably due to the
lack of power as there were only 16 current smokers,
representing 2.6 % of our patient cohort.
There was an association between CCI score and LOS
[effect size: 0.21 (0.0434–0.381); p = 0.014] with higher
CCI scores having an increased likelihood of longer hos-
pital LOS, and consequently higher costs, as summarized
in Figs. 1 and 2. The average LOS for our patients with a
CCI score of 0 was 5.8 days ($26,274.00); patients with a
CCI score of 1 had an average LOS of 6.5 days
($30,577.50); patients with a CCI score of 2 had an average
LOS of 7.72 days ($34,971.60); patients with a CCI score
of three or greater had an average LOS of 7.77 days
($35,175.45). Therefore, the financial difference between
treating a patient with a CCI score of 0 as compared to a
patient with a CCI score of 2 was an additional $8,697.60
per patient.
Discussion
We found that increasing CCI scores are associated with
longer LOS following hip fracture, and we quantified the
cost burden attributable to this prolonged LOS. Our finding
supports the work of other authors who have noted a re-
lationship between comorbidities and prolonged LOS and
increased hospital costs following hip fracture [2]; how-
ever, our study is the first to assess this relationship using
the CCI.
Because there are currently no other published studies
examining the relationship between the CCI score and LOS
and hospital costs following hip fractures, we compared
our findings with those reported for total joint arthroplasty.
In the Tien et al. [12] study of total joint arthroplasty in
Taiwan, a CCI score of 1 or higher correlated well with
length of hospitalization and higher hospital costs. In par-
allel, our study is the first to suggest that an increased CCI
score is associated with a prolonged LOS and increased
hospital costs after hip fracture treatment. The relationship
between the CCI score and LOS following different pro-
cedures implies that the CCI score can succinctly sum-
marize a patient’s overall health status, and therefore
makes it a versatile tool to use for risk stratification in
negotiating bundled payments. The CCI score has also
been shown to be associated with short-term mortality
following hip fractures [7–9] and a relationship between
higher CCI scores and readmission rates following any
orthopedic procedure has also been identified [10].
There are several factors to consider in the interpretation
of our results. First, the comorbidities of our patient
population and the cost of inpatient care reflect the practice
of a single, tertiary care, academic medical center, and
further analysis is necessary to determine whether our
findings are applicable to other surgical settings. Secondly,
we only evaluated bundled payments that were related to
the inpatient cost from the index procedure, and although
this limitation does not affect our findings regarding the
association between the CCI score and increased hospital



















































75.35 Insertion of intramedullary nail – femur 6 1.0 6.00 $27,180.00
78.59 Percutaneous pinning of hip 14 2.3 5.36 $24,280.80
79.352 Open reduction internal fixation of femoral neck 1 0.2 3.00 $13,590.00
79.353 Open reduction internal fixation of femoral head 2 0.3 3.00 $13,590.00
79.783 Percutaneous pinning of lower extremity 2 0.3 5.50 $24,915.00
79.855 Open reduction internal fixation of hip with compression screw and plate 3 0.5 6.00 $27,180.00
79.857 Open reduction internal fixation of intertrochanteric fx 20 3.3 5.05 $22,876.50
81.6 Arthroplasty of hip – total primary 2 0.3 6.50 $29,445.00
846 Hemiarthroplasty of hip 29 4.7 5.95 $26,953.50
7125 Hemiarthroplasty hip – partial 121 19.7 7.72 $34,971.60
27130 Arthroplasty, acetabular and proximal femoral prosthetic replacement
with or without autograft/allograft
37 6.0 8.41 $38,097.30
27130A Arthroplasty, acetabular and proximal femoral prosthetic replacement
with or without autograft/allograft, anterior
5 0.8 9.00 $40,770.00
27235 Percutaneous skeletal fixation, femoral fx, proximal, neck 45 7.3 5.67 $25,685.10
27236 Treatment, open femoral fx, proximal end, neck, internal fixation/
prosthetic replacement
86 14.0 7.12 $32,253.60
27244 Treatment, inter/per/subtrochanteric femoral fx, with plate/screw type
implant,with or without cerclage
117 19.0 7.28 $32,978.40
27245 Open treatment, inter/per/subtrochanteric femoral fx, with intermedullary
implant, with or without screw/cerclage
82 13.3 6.95 $31,483.50
27248 Open treatment, greater trochanteric fx, with or without internal or
external fixation
5 0.8 4.40 $19,932.00
27254 Open treatment, hip dislocation, traumatic, with acetabular wall/femoral
head fx, with or without internal or external fixation
1 0.2 7.00 $31,710.00
27506 Open treatment, femoral shaft fx, with insertion, intramedullary implant,
with or without screw/cerclage
30 4.9 6.30 $28,539.00
27507 Open treatment, femoral shaft fx, with plate/screws, with or without
cerclage
6 1.0 3.50 $15,855.00
27509 Percutaneous skeletal fixation, femoral fx, distal end 1 0.2 3.00 $13,590.00
Fig. 1 Mean length of stay per CCI score calculated from patient’s
medical comorbidities found in charts Fig. 2 Mean cost of stay per CCI score
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costs, it is important to recognize that the cost burden we
found represents the minimum additional cost incurred, and
more research is needed to quantify the relationship be-
tween the CCI score and other factors which would affect
hospital costs in a bundled payment model.
The rationale for bundled payments is to incentivize
various providers to collaboratively deliver high-quality
care at the lowest possible cost, but several authors have
noted potential downsides of this payment model, both for
the patients and the providers. With respect to the former,
Bozic et al. [13] noted that bundled payment models si-
multaneously create the incentive to withhold care, and
because of this, there is a growing awareness that institu-
tions need methods to calculate the specific cost burden of
patient factors associated with a particular procedure prior
to entering into a bundled payment reimbursement agree-
ment [5]. This is not only imperative for the financial
solvency of the institution [5], but it is also necessary to
ensure that more complex patients with multiple comorbid
conditions receive the care they need. The results of our
study, which show the impact of increasing CCI scores on
hospital LOS and its financial implications further high-
light the importance of quantifying the specific cost burden
of patient factors, both to protect the financial interests of
the institution and to ensure that funds are allotted to meet
the needs of medically complex patients. In summary, the
results of our study suggest that the CCI score may have a
role in predicting hospital costs and negotiating reim-
bursement rates for the treatment of hip fractures, and,
based on our results, more research is warranted to evaluate
the impact of the CCI score on other costs included in
bundled payments.
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